Key result
Synthetic ANP bolus boosts urine volume and sodium excretion in renal disease without dose response.
Why the study?
The diuretic and natriuretic responses to exogenous synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome were evaluated to understand renal and hemodynamic effects.
Does synthetic atrial natriuretic peptide increase urine volume and sodium excretion in patients with chronic renal failure or nephrotic syndrome?
RCT
Does synthetic atrial natriuretic peptide increase urine volume and sodium excretion in patients with chronic renal failure or nephrotic syndrome?
Synthetic atrial natriuretic peptide induces significant natriuresis in patients with chronic renal failure and nephrotic syndrome, with a more preserved renal response in nephrotic syndrome.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; leaves open natriuretic effects for randomized confirmation.
The diuretic and natriuretic responses to exogenous synthetic atrial natriuretic peptide (ANP) were evaluated in patients with chronic renal failure (CRF) or nephrotic syndrome (NS). Patients were studied after an oral water load (8 ml/kg in CRF and 20 ml/kg in NS patients). A short intravenous bolus of either a placebo or ANP was administered when urine output was stable. In each group of patients, three doses of ANP were injected at 24 h intervals, i.e., 1.0, 1.5, and 2.0 micrograms/kg in the CRF and 1.0, 1.5, and 3.0 micrograms/kg in the NS group. Blood pressure and heart rate were monitored throughout the study and urinary volume and electrolyte excretion were measured every 20 min up to 3 h after the bolus. An acute and transient fall in blood pressure was observed immediately after the ANP injection. It was more pronounced in CRF than in NS patients. In CRF patients, ANP caused only a slight increase in urinary volume (13.5-44% over baseline) but a significant increase in urinary sodium excretion (45-114% over baseline). In NS patients, significant increases in both urine volume (60-105%) and sodium excretion (149-248%) were also found. In these latter patients, the renal response to ANP appeared to be better preserved. The hemodynamic and renal changes induced by ANP occurred mainly during the first 20 min following the ANP administration, when the peak plasma ANP levels were obtained. However, no clear dose-response effect could be evidenced in either group with the three doses of ANP chosen in this study.
No takes yet. Share an insight, caveat, or question.
Burnier et al. (1989) conducted an RCT in Chronic renal failure or nephrotic syndrome. Synthetic atrial natriuretic peptide (ANP) vs. Placebo was evaluated on Urinary volume and sodium excretion. Bolus injections of synthetic atrial natriuretic peptide increased urinary volume and sodium excretion in patients with chronic renal failure or nephrotic syndrome, with no clear dose-response effect.
Synapse has enriched 10 related papers. Consider them for comparative context: